Microbiome Analysis in Gastric Intestinal Metaplasia and in Gastric Cancer and Subtypes Correlation
Microbiome Analysis in Patients With Gastric Intestinal Metaplasia and in Patients With Gastric Cancer and Correlation With the Subtypes of the Lesions
Sponsor: University Hospital, Ioannina
A observational or N/A phase clinical study on Gastric Cancer and Gastric Intestinal Metaplasia, this trial is ongoing. The trial is conducted by University Hospital, Ioannina and has accumulated 8 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jun 2023 — Jul 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Dec 2021 — Jun 2023 [monthly]
Active Not Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
May 2020 — Nov 2020 [monthly]
Active Not Recruiting
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Ioannina
- University of Ioannina
For direct contact, visit the study record on ClinicalTrials.gov .